GIANCANE, GABRIELLA
 Distribuzione geografica
Continente #
EU - Europa 3.758
AS - Asia 486
NA - Nord America 456
Continente sconosciuto - Info sul continente non disponibili 132
SA - Sud America 47
AF - Africa 12
Totale 4.891
Nazione #
IT - Italia 3.672
US - Stati Uniti d'America 418
SG - Singapore 188
CN - Cina 117
VN - Vietnam 83
BD - Bangladesh 41
FR - Francia 34
BR - Brasile 26
HK - Hong Kong 20
CA - Canada 16
DE - Germania 16
GB - Regno Unito 8
IN - India 8
AR - Argentina 7
CO - Colombia 6
JP - Giappone 5
ZA - Sudafrica 5
DO - Repubblica Dominicana 4
IQ - Iraq 4
JM - Giamaica 4
MX - Messico 4
RO - Romania 4
EC - Ecuador 3
FI - Finlandia 3
NL - Olanda 3
PK - Pakistan 3
RU - Federazione Russa 3
UA - Ucraina 3
VE - Venezuela 3
AM - Armenia 2
AT - Austria 2
CR - Costa Rica 2
GT - Guatemala 2
ID - Indonesia 2
MA - Marocco 2
PH - Filippine 2
SA - Arabia Saudita 2
TR - Turchia 2
TT - Trinidad e Tobago 2
CH - Svizzera 1
CW - ???statistics.table.value.countryCode.CW??? 1
CZ - Repubblica Ceca 1
DZ - Algeria 1
EG - Egitto 1
ES - Italia 1
ET - Etiopia 1
GR - Grecia 1
HN - Honduras 1
HR - Croazia 1
IE - Irlanda 1
IR - Iran 1
KZ - Kazakistan 1
LB - Libano 1
LT - Lituania 1
MQ - Martinica 1
OM - Oman 1
PA - Panama 1
PE - Perù 1
PL - Polonia 1
PR - Porto Rico 1
SC - Seychelles 1
SE - Svezia 1
SK - Slovacchia (Repubblica Slovacca) 1
SN - Senegal 1
TH - Thailandia 1
TW - Taiwan 1
UY - Uruguay 1
UZ - Uzbekistan 1
Totale 4.760
Città #
Genova 1.878
Genoa 1.071
Rapallo 362
Vado Ligure 303
San Jose 116
Singapore 94
Ashburn 38
Lauterbourg 30
New York 24
Beijing 22
Ho Chi Minh City 19
Hong Kong 19
Council Bluffs 18
Hanoi 17
Santa Clara 13
Chicago 8
Haiphong 8
Milan 7
Frankfurt am Main 6
Los Angeles 6
Montreal 6
Bordighera 5
Dallas 5
Rome 5
Berlin 4
Buffalo 4
Chennai 4
Da Nang 4
Houston 4
Orem 4
Tokyo 4
Vedano Olona 4
Biên Hòa 3
Boston 3
Changsha 3
Kingston 3
Kyiv 3
Manchester 3
Mexico City 3
Naples 3
North Charleston 3
Philadelphia 3
Phoenix 3
Piscataway 3
Princeton 3
Santo Domingo 3
São Paulo 3
Thái Bình 3
Tianjin 3
Wesley Chapel 3
Abingdon 2
Acalanes Ridge 2
Agadir 2
Altoona 2
Amsterdam 2
Belleville 2
Bogotá 2
Brasília 2
Brockton 2
Can Tho 2
City of London 2
Denver 2
Detroit 2
Fredericksburg 2
Guatemala City 2
Helsinki 2
Indpls 2
Islamabad 2
Johannesburg 2
Las Vegas 2
Leipzig 2
L’Aquila 2
Moscow 2
Nuremberg 2
Orlando 2
Pittsburgh 2
Portland 2
Queens 2
Riverside 2
Rosarno 2
San Francisco 2
Shanghai 2
Toronto 2
Washington 2
Addis Ababa 1
Alagoinhas 1
Albuquerque 1
Alliston 1
Ancona 1
Antioch 1
Araçoiaba 1
Argenta 1
Arima 1
Arlington 1
Athens 1
Atlanta 1
Baghdad 1
Baltimore 1
Bangkok 1
Banyuwangi 1
Totale 4.250
Nome #
Juvenile Idiopathic Arthritis: Diagnosis and Treatment 224
Development and initial validation of a composite disease activity score for systemic juvenile idiopathic arthritis 209
Pharmacovigilance in juvenile idiopathic arthritis patients (pharmachild) treated with biologic agents and/or methotrexate. A Pediatric Rheumatology International Trials Organisation (PRINTO)/Pediatric Rheumatology European Society (PRES) registry 199
Agreement among musculoskeletal pediatric specialists in the assessment of radiographic joint damage in juvenile idiopathic arthritis. 189
IL-1 Inhibition in Systemic Juvenile Idiopathic Arthritis 189
Clinical outcome measures in juvenile idiopathic arthritis 185
Current Research in Outcome Measures for Pediatric Rheumatic and Autoinflammatory Diseases 174
A prediction rule for lack of achievement of inactive disease with methotrexate as the sole disease-modifying antirheumatic therapy in juvenile idiopathic arthritis 171
Disease activity and damage in juvenile idiopathic arthritis: Methotrexate era versus biologic era 166
The PRINTO evidence-based proposal for glucocorticoids tapering/discontinuation in new onset juvenile dermatomyositis patients 166
EULAR recommendations for the management of familial Mediterranean fever 165
Evidence-based recommendations for genetic diagnosis of familial Mediterranean fever 165
Phenotypic variability and disparities in treatment and outcomes of childhood arthritis throughout the world: an observational cohort study 162
Recent therapeutic advances in juvenile idiopathic arthritis 160
Pharmacovigilance in juvenile idiopathic arthritis patients treated with biologic or synthetic drugs: combined data of more than 15,000 patients from Pharmachild and national registries 160
Temporomandibular joint involvement in juvenile idiopathic arthritis: Reliability and validity of a screening protocol for the rheumatologist 153
Update on the pathogenesis and treatment of juvenile idiopathic arthritis 150
Frequency of radiographic damage and progression in individual joints in children with juvenile idiopathic arthritis. 149
Determinants of discordance between criteria for inactive disease and low disease activity in juvenile idiopathic arhritis 137
Primary hypertrophic osteoarthropathy: An update on patient features and treatment 133
Analysis of arthritis flares after achievement of inactive disease with methotrexate monotherapy in juvenile idiopathic arthritis 129
Information technology in paediatric rheumatology 126
Open issues in the assessment and management of pain in juvenile idiopathic arthritis 126
Treatment of juvenile idiopathic arthritis: what's new? 126
Temporomandibular Joint Involvement is Associated with Quality of Life, Disability and High Disease Activity in Juvenile Idiopathic Arthritis 125
A clinical prediction model for estimating the risk of developing uveitis in patients with juvenile idiopathic arthritis 117
Paediatric rheumatic disease: What is the best definition of clinical remission in JIA? 114
The Effect of Morning Stiffness Duration on the Definition of Clinically Inactive Disease in Juvenile Idiopathic Arthritis 110
Growth and puberty in juvenile dermatomyositis: a longitudinal cohort study 105
Tocilizumab may slow radiographic progression in patients with systemic or polyarticular-course juvenile idiopathic arthritis: Post hoc radiographic analysis from two randomized controlled trials 102
A prediction rule for polyarticular extension in oligoarticular-onset juvenile idiopathic arthritis 101
Drivers of non-zero physician global scores during periods of inactive disease in juvenile idiopathic arthritis 101
Outcome Scores in Pediatric Rheumatology 58
Real-world comparison of the effects of etanercept and adalimumab on well-being in non-systemic juvenile idiopathic arthritis: a propensity score matched cohort study 45
Totale 4.891
Categoria #
all - tutte 17.789
article - articoli 17.258
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 35.047


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022374 0 0 18 32 14 38 15 79 43 51 20 64
2022/2023424 35 40 8 40 84 60 1 34 71 1 45 5
2023/2024243 17 32 4 39 21 18 19 14 16 11 10 42
2024/2025774 32 50 34 60 70 71 78 158 23 42 85 71
2025/20261.249 201 27 50 53 181 94 183 41 89 148 77 105
2026/2027199 109 60 30 0 0 0 0 0 0 0 0 0
Totale 4.891